AYTU logo

Aytu BioPharma (AYTU) Depreciation And Amortization

Annual D&A

$8.27 M
-$543.00 K-6.16%

June 30, 2024

Summary

Performance

1-Year Change

-6.16%

3-Year Change

-10.1%

5-Year Change

+203.33%

15-Year Change

+89.52%

AYTU Depreciation And Amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

70.67%
AYTU annual depreciation & amortization is higher than 70.67% of companies in Healthcare sector

High & Low

All-time High

$10.15 M
AYTU annual depreciation & amortization is currently -18.47% below its historical high of $10.15 million

3-Year Low

$8.27 M
AYTU annual depreciation & amortization is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Jun 30, 2024
AYTU previous annual earnings announcement was published on Jun 30, 2024

Next Annual Earnings Report Date

N/A
AYTU next annual earnings announcement has not yet been scheduled

Related metrics

Annual Total Expenses

$83.89 M
AYTU annual total expenses is $83.89 million

Annual Operating Expenses

$57.48 M
AYTU annual total operating expenses is $57.48 million

Annual Cost Of Goods Sold

$26.42 M
AYTU annual cost of goods sold is $26.42 million

Annual Interest Expense

$4.79 M
AYTU annual interest expense is $4.79 million

Quarterly D&A

$1.43 M
-$517.00 K-26.59%

September 30, 2024

Summary

Performance

3-Month Change

-26.59%

1-Year Change

-22.57%

3-Year Change

-46.69%

5-Year Change

-27.67%

AYTU Quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

63.61%
AYTU quarterly depreciation & amortization is higher than 63.61% of companies in Healthcare sector

High & Low

All-time High

$3.32 M
AYTU quarterly depreciation & amortization is currently -57.06% below its historical high of $3.32 million

3-Year Low

$1.43 M
AYTU quarterly depreciation & amortization is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
AYTU previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 14, 2025
AYTU next earnings announcement is scheduled for Feb 14, 2025

Related metrics

Quarterly Total Expenses

$16.72 M
AYTU quarterly total expenses is $16.72 million

Quarterly Operating Expenses

$12.13 M
AYTU quarterly total operating expenses is $12.13 million

Quarterly Cost Of Goods Sold

$4.59 M
AYTU quarterly cost of goods sold is $4.59 million

Quarterly Interest Expense

$994.00 K
AYTU quarterly interest expense is $994.00 thousand

TTM D&A

$7.86 M
-$416.00 K-5.03%

September 30, 2024

Summary

Performance

3-Month Change

-5.03%

1-Year Change

-5.99%

3-Year Change

-20.19%

5-Year Change

+0.57%

AYTU TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

68.61%
AYTU TTM depreciation & amortization is higher than 68.61% of companies in Healthcare sector

High & Low

All-time High

$11.25 M
AYTU TTM depreciation & amortization is currently -30.16% below its historical high of $11.25 million

3-Year Low

$7.86 M
AYTU TTM depreciation & amortization is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
AYTU previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 14, 2025
AYTU next earnings announcement is scheduled for Feb 14, 2025

Related metrics

Annual Total Expenses

$83.89 M
AYTU annual total expenses is $83.89 million

Annual Operating Expenses

$57.48 M
AYTU annual total operating expenses is $57.48 million

TTM Cost Of Goods Sold

$23.69 M
AYTU TTM cost of goods sold is $23.69 million

TTM Interest Expense

$994.00 K
AYTU TTM interest expense is $994.00 thousand

AYTU Depreciation And Amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-6.2%-22.6%-6.0%
3 y3 years-10.1%-46.7%-20.2%
5 y5 years+203.3%-27.7%+0.6%

AYTU Depreciation And Amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-18.5%at low-46.6%at low-30.2%at low
5 y5-year-18.5%+203.3%-57.1%+10.8%-30.2%+115.0%
alltimeall time-18.5%>+9999.0%-57.1%>+9999.0%-30.2%>+9999.0%

Aytu BioPharma Depreciation And Amortization History

DateAnnualQuarterlyTTM
Sep 2024
-
$1.43 M(-26.6%)
$7.86 M(-5.0%)
Jun 2024
$8.27 M(-6.2%)
$1.94 M(+1.3%)
$8.27 M(-2.0%)
Mar 2024
-
$1.92 M(-25.2%)
$8.44 M(-3.1%)
Dec 2023
-
$2.57 M(+39.2%)
$8.72 M(+4.3%)
Sep 2023
-
$1.84 M(-12.9%)
$8.36 M(-5.2%)
Jun 2023
$8.81 M(-13.1%)
$2.12 M(-3.5%)
$8.81 M(-1.2%)
Mar 2023
-
$2.19 M(-0.6%)
$8.92 M(-4.1%)
Dec 2022
-
$2.21 M(-4.1%)
$9.30 M(-4.8%)
Sep 2022
-
$2.30 M(+3.6%)
$9.77 M(-3.7%)
Jun 2022
$10.15 M(+10.3%)
$2.22 M(-13.8%)
$10.15 M(-9.8%)
Mar 2022
-
$2.57 M(-3.8%)
$11.25 M(+5.6%)
Dec 2021
-
$2.67 M(-0.1%)
$10.65 M(+8.2%)
Sep 2021
-
$2.68 M(-19.4%)
$9.84 M(+7.0%)
Jun 2021
$9.20 M(+61.0%)
$3.32 M(+68.4%)
$9.20 M(+17.8%)
Mar 2021
-
$1.97 M(+5.5%)
$7.81 M(+4.7%)
Dec 2020
-
$1.87 M(-8.1%)
$7.46 M(+8.5%)
Sep 2020
-
$2.04 M(+5.2%)
$6.88 M(+20.4%)
Jun 2020
$5.71 M(+109.5%)
$1.93 M(+19.2%)
$5.71 M(+26.0%)
Mar 2020
-
$1.62 M(+26.0%)
$4.53 M(+24.1%)
Dec 2019
-
$1.29 M(+48.2%)
$3.65 M(+20.2%)
Sep 2019
-
$869.30 K(+15.5%)
$3.04 M(+11.5%)
Jun 2019
$2.73 M(+5.2%)
$752.90 K(+1.3%)
$2.73 M(+5.3%)
Mar 2019
-
$743.50 K(+10.3%)
$2.59 M(+3.3%)
Dec 2018
-
$673.90 K(+21.0%)
$2.51 M(+0.5%)
Sep 2018
-
$556.80 K(-9.6%)
$2.49 M(-3.7%)
Jun 2018
$2.59 M(-40.6%)
$615.80 K(-6.8%)
$2.59 M(-36.4%)
Mar 2018
-
$660.40 K(-0.2%)
$4.08 M(+3.0%)
Dec 2017
-
$661.70 K(+1.3%)
$3.96 M(-5.7%)
Sep 2017
-
$653.30 K(-68.9%)
$4.20 M(-3.9%)
Jun 2017
$4.36 M(+398.9%)
$2.10 M(+288.3%)
$4.36 M(+61.3%)
Mar 2017
-
$541.00 K(-39.9%)
$2.71 M(+14.9%)
Dec 2016
-
$900.80 K(+9.6%)
$2.36 M(+50.2%)
Sep 2016
-
$822.20 K(+86.3%)
$1.57 M(+79.3%)
Jun 2016
$874.80 K
$441.30 K(+131.0%)
$874.70 K(+101.8%)
Mar 2016
-
$191.00 K(+68.3%)
$433.40 K(+78.8%)
Dec 2015
-
$113.50 K(-11.9%)
$242.40 K(+84.6%)
DateAnnualQuarterlyTTM
Sep 2015
-
$128.90 K(>+9900.0%)
$131.30 K(+2635.4%)
Jun 2015
$118.20 K(+2362.5%)
-
-
Feb 2015
-
$1200.00(0.0%)
$4800.00(0.0%)
Nov 2014
-
$1200.00(0.0%)
$4800.00(0.0%)
Aug 2014
$4800.00(-95.1%)
$1200.00(0.0%)
$4800.00(0.0%)
Jun 2014
$97.50 K(+1889.8%)
-
-
May 2014
-
$1200.00(0.0%)
$4800.00(0.0%)
Feb 2014
-
$1200.00(0.0%)
$4800.00(0.0%)
Nov 2013
-
$1200.00(0.0%)
$4800.00(-2.0%)
Aug 2013
$4900.00(-21.0%)
$1200.00(0.0%)
$4900.00(-3.9%)
May 2013
-
$1200.00(0.0%)
$5100.00(-5.6%)
Feb 2013
-
$1200.00(-7.7%)
$5400.00(-8.5%)
Nov 2012
-
$1300.00(-7.1%)
$5900.00(-6.3%)
Aug 2012
$6200.00(-8.8%)
$1400.00(-6.7%)
$6300.00(-4.5%)
May 2012
-
$1500.00(-11.8%)
$6600.00(-2.9%)
Feb 2012
-
$1700.00(0.0%)
$6800.00(-2.9%)
Nov 2011
-
$1700.00(0.0%)
$7000.00(+2.9%)
Aug 2011
$6800.00(-26.1%)
$1700.00(0.0%)
$6800.00(-11.7%)
May 2011
-
$1700.00(-10.5%)
$7700.00(-8.3%)
Feb 2011
-
$1900.00(+26.7%)
$8400.00(-2.3%)
Nov 2010
-
$1500.00(-42.3%)
$8600.00(-6.5%)
Aug 2010
$9200.00(+10.8%)
$2600.00(+8.3%)
$9200.00(+5.7%)
May 2010
-
$2400.00(+14.3%)
$8700.00(+3.6%)
Feb 2010
-
$2100.00(0.0%)
$8400.00(-6.7%)
Nov 2009
-
$2100.00(0.0%)
$9000.00(+7.1%)
Aug 2009
$8300.00(+10.7%)
$2100.00(0.0%)
$8400.00(0.0%)
May 2009
-
$2100.00(-22.2%)
$8400.00(+1.2%)
Feb 2009
-
$2700.00(+80.0%)
$8300.00(+13.7%)
Nov 2008
-
$1500.00(-28.6%)
$7300.00(-2.7%)
Aug 2008
$7500.00(+17.2%)
$2100.00(+5.0%)
$7500.00(+7.1%)
May 2008
-
$2000.00(+17.6%)
$7000.00(+6.1%)
Feb 2008
-
$1700.00(0.0%)
$6600.00(+1.5%)
Nov 2007
-
$1700.00(+6.3%)
$6500.00(+1.6%)
Aug 2007
$6400.00
$1600.00(0.0%)
$6400.00(+33.3%)
May 2007
-
$1600.00(0.0%)
$4800.00(+50.0%)
Feb 2007
-
$1600.00(0.0%)
$3200.00(+100.0%)
Nov 2006
-
$1600.00
$1600.00

FAQ

  • What is Aytu BioPharma annual depreciation & amortization?
  • What is the all time high annual D&A for Aytu BioPharma?
  • What is Aytu BioPharma annual D&A year-on-year change?
  • What is Aytu BioPharma quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Aytu BioPharma?
  • What is Aytu BioPharma quarterly D&A year-on-year change?
  • What is Aytu BioPharma TTM depreciation & amortization?
  • What is the all time high TTM D&A for Aytu BioPharma?
  • What is Aytu BioPharma TTM D&A year-on-year change?

What is Aytu BioPharma annual depreciation & amortization?

The current annual D&A of AYTU is $8.27 M

What is the all time high annual D&A for Aytu BioPharma?

Aytu BioPharma all-time high annual depreciation & amortization is $10.15 M

What is Aytu BioPharma annual D&A year-on-year change?

Over the past year, AYTU annual depreciation & amortization has changed by -$543.00 K (-6.16%)

What is Aytu BioPharma quarterly depreciation & amortization?

The current quarterly D&A of AYTU is $1.43 M

What is the all time high quarterly D&A for Aytu BioPharma?

Aytu BioPharma all-time high quarterly depreciation & amortization is $3.32 M

What is Aytu BioPharma quarterly D&A year-on-year change?

Over the past year, AYTU quarterly depreciation & amortization has changed by -$416.00 K (-22.57%)

What is Aytu BioPharma TTM depreciation & amortization?

The current TTM D&A of AYTU is $7.86 M

What is the all time high TTM D&A for Aytu BioPharma?

Aytu BioPharma all-time high TTM depreciation & amortization is $11.25 M

What is Aytu BioPharma TTM D&A year-on-year change?

Over the past year, AYTU TTM depreciation & amortization has changed by -$501.00 K (-5.99%)